-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Progyny, Raises Price Target to $27

Benzinga·05/18/2026 14:23:54
Listen to the news
Barclays analyst Glen Santangelo maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $23 to $27.